Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. CRISPR Therapeutics AG’s current trading price is -56.76% away from its 52-week high, while its distance from the 52-week low is 3.12%. The stock’s price range over this period has fluctuated between $38.20 and $91.10. The company, operating within the financial sector, had a trading volume of approximately 1.41 million for the day, which was noticeably lower than the average daily share volume of 1.67 million over the last 3 months.
CRISPR Therapeutics AG experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $91.10 on 02/22/24, while the lowest price for the same period was registered at $38.20 on 12/30/24.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
CRISPR Therapeutics AG (CRSP) has experienced a quarterly decline of -13.24% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 3.36B and boasts a workforce of 407 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 46.91, with a change in price of -8.39. Similarly, CRISPR Therapeutics AG recorded 1,425,975 in trading volume during the last 100 days, posting a change of -17.53%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for CRSP stands at 0.12. Similarly, the long-term debt-to-equity ratio is also 0.11.
CRSP Stock Stochastic Average
Today’s raw stochastic average for CRISPR Therapeutics AG over the last 50 days is 6.04%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 11.27%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 20.51% and 23.43%, respectively.
CRSP Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Year to date metric has recorded a gain of 0.08%.However, over the last six months, we can see a stronger performance of -30.66%. Over the last 30 days, the price of CRSP has leaped by -20.96%. And in the last five days, it has fallen by -4.92%.
